Chronic lower extremity ischemia: A human model of ischemic tolerance

Canadian Journal of Surgery

Volumn 47, Issue 5, 2004, Pages 352-358

  Badhwar, Amit ^a   Forbes, Thomas L ^a   Lovell, Marge B ^a   Dungey, Alison A ^a   McCarter, Sarah D ^a   Scott, Jeffrey R ^a   DeRose, Guy ^a   Harris, Kenneth A ^a   Potter, Richard F ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; LACTATE DEHYDROGENASE; MYOGLOBIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; BYPASS SURGERY; CHRONIC DISEASE; CLINICAL ARTICLE; CONDITIONING; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE MODEL; DISEASE SEVERITY; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEG ISCHEMIA; LERICHE SYNDROME; MALE; MUSCLE ISCHEMIA; MUSCLE PERFUSION; PROTECTION; PROTEIN BLOOD LEVEL; REPERFUSION; SKELETAL MUSCLE; SURGICAL TECHNIQUE; VASCULAR SURGERY;

AGED; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHRONIC DISEASE; CONSTRICTION; FEMALE; HUMANS; ISCHEMIA; ISCHEMIC PRECONDITIONING; LOWER EXTREMITY; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MUSCLE, SKELETAL; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 9744227940     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
2. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 1986;251:H1306-15.
3. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, et al. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 1997;81:1094-107.
4. Bolli R. The late phase of preconditioning. Circ Res 2000;87:972-83.
5. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993;88:1264-72.
6. Baxter GF, Marber MS, Patel VC, Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 1994;90:2993-3000.
7. 1 receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase. Circulation 2000;101:2841-8.
8. Gabel SA, London RE, Funk CD, Steenbergen C, Murphy E. Leukocyte-type 12-lipoxygenase-deficient mice show impaired ischemic preconditioning-induced cardioprotection. Am J Physiol Heart Circ Physiol 2001;280:H1963-9.
9. Lochner A, Genade S, Tromp E, Podzuweit T, Moolman JA. Ischemic preconditioning and the beta-adrenergic signal transduction pathway. Circulation 1999;100:958-66.
10. Meldrum DR, Dinarello CA, Shames BD, Cleveland JCJ, Cain BS, Banerjee A, et al. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production: potential ultimate effector mechanism of preconditioning. Circulation 1998;98(19):II214-8.
11. Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, et al. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ Res 2000;86:144-51.
12. Song QJ, Li YJ, Deng HW. Early and delayed cardioprotection by heat stress is mediated by calcitonin gene-related peptide. Naunyn Schmiedebergs Arch Pharmacol 1999;359:477-83.
13. Takano H, Tang XL, Kodani E, Bolli R. Late preconditioning enhances recovery of myocardial function after infarction in conscious rabbits. Am J Physiol Heart Circ Physiol 2000;279(5):H2372-81.
14. Tanhehco EJ, Yasojima K, McGeer PL, Washington RA, Kilgore KS, Homeister JW, et al. Preconditioning reduces tissue complement gene expression in the rabbit isolated heart. Am J Physiol 1999;277:H2373-80.
15. Yellon DM, Alkhulaifi AM, Browne EE, Pugsley WB. Ischæmic preconditioning limits infarct size in the rat heart. Cardiovasc Res 1992;26:983-7.
16. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-7.
17. Kitagawa K, Matsumoto M, Kuwabara K, Tagaya M, Ohtsuki T, Hata R, et al. "Ischemic tolerance" phenomenon detected in various brain regions. Brain Res 1991;561:203-11.
18. 3 receptors. Am J Physiol Renal Physiol 2000;278 (3):F380-7.
19. Raju VS, Maines MD. Renal ischemia/reperfusion up-regulates heme oxygenase-1 (HSP32) expression and increases cGMP in rat heart. J Pharmacol Exp Ther 1996;277(3):1814-22.
20. Osborne DL, Aw TY, Cepinskas G, Kvietys PR. Development of ischemia/reperfusion tolerance in the rat small intestine: an epithelium-independent event. J Clin Invest 1994;94(5):1910-8.
21. Hotter G, Closa D, Prados M, Fernandez-Cruz L, Prats N, Gelpi E, et al. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun 1996;222:27-32.
22. Peralta C, Prats N, Xaus C, Gelpi E, Rosello-Catafau J. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 1999;30:1481-9.
23. Peralta C, Closa D, Xaus C, Gelpi E, Rosello-Catafau J, Hotter G. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 1998;28:768-73.
24. 2 receptors. Hepatology 1999;29:126-32.
25. Peralta C, Bartrons R, Riera L, Manzano A, Xaus C, Gelpi E, et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol 2000;279:G163-71.
26. Sawaya DEJ, Brown M, Minardi A, Bilton B, Burney D, Granger DN, et al. The role of ischemic preconditioning in the recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. J Surg Res 1999;85:163-70.
27. Pudupakkam S, Harris KA, Jamieson WG, DeRose G, Scott JA, Carson MW, et al. Ischemic tolerance in skeletal muscle: role of nitric oxide. Am J Physiol 1998;275:H94-9.
28. Gunaydin B, Cakici I, Soncul H, Kalaycioglu S, Cevik C, Sancak B, et al. Does remote organ ischemia trigger cardiac preconditioning during coronary artery surgery? Pharmacol Res 2000;41:493-6.
29. Cleveland JC Jr, Raeburn C, Harken AH. Clinical applications of ischemic preconditioning: from head to toe. Surgery 2001;129:664-7.
30. Hawaleshka A, Jacobsohn E. Ischæmic preconditioning: mechanisms and potential clinical applications. Can J Anesth 1998;45:670-82.
31. Lee HT, LaFaro RJ, Reed GE. Pretreatment of human myocardium with adenosine during open heart surgery. J Card Surg 1995;10:665-76.
32. Haggart PC, Ludman PF, Bradbury AW. Cardiac troponin: a new biochemical marker for peri-operative myocardial injury. Eur J Vasc Endovasc Surg 2001;22:301-5.
33. Gute DC, Ishida T, Yarimizu K, Korthuis RJ. Inflammatory responses to ischemia and reperfusion in skeletal muscle [review]. Mol Cell Biochem 1998;179(1-2): 169-87.
34. Kishi M, Richard LF, Webster RO, Dahms TE. Role of neutrophils in xanthine/xanthine oxidase-induced oxidant injury in isolated rabbit lungs. J Appl Physiol 1999;87(6):2319-25.
35. Lum H, Roebuck BCA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 2001;280(4):C719-41.
36. Schlag MG, Harris KA, Potter RF. Role of leukocyte accumulation and oxygen radicals in ischemia-reperfusion-induced injury in skeletal muscle. Am J Physiol Heart Circ Physiol 2001;280(4):H1716-21.
37. Moreno-Manzano V, Ishikawa Y, Lucio-Cazana J, Kitamura M. Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-alpha-induced apoptosis of rat mesangial cells. J Biol Chem 2000;275(17): 12684-91.
38. Faist E, Baue AE, Dittmer H, Heberer G. Multiple organ failure in polytrauma patients. J Trauma 1983;23(9):775-87.
39. Huber TS, Harward TR, Flynn TC, Albright JL, Seeger JM. Operative mortality rates after elective infrarenal aortic reconstructions. J Vasc Surg 1995;22:287-93.
40. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV. Multiple-organ-failure syndrome. Arch Surg 1986;121:196-208.
41. Bankwala Z, Hale SL, Kloner RA. Alpha-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. Circulation 1994;90(2):1023-8.
42. Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 1997;96 (5):1641-6.
43. Dickson EW, Lorbar M, Porcaro WA, Fenton RA, Reinhardt CP, Gysembergh A, et al. Rabbit heart can be "preconditioned" via transfer of coronary effluent. Am J Physiol 1999;277(6 Pt 2):H2451-57.
44. Lindsay T, Walker PM, Mickle DA, Romaschin AD. Measurement of hydroxy-conjugated dienes after ischemia-reperfusion in canine skeletal muscle. Am J Physiol 1988;254(3 Pt2):H578-H583.
45. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993;87(3): 893-9.
46. Sanada S, Kitakaze M, Asanuma H, Harada K, Ogita H, Node K, et al. Role of mitochondrial and sarcolemmal K(ATP) channels in ischemic preconditioning of the canine heart. Am J Physiol Heart Circ Physiol 2001;280(1):H256-H263.
47. Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 1997;25:934-7.
48. Takashi E, Wang Y, Ashraf M. Activation of mitochondrial K(ATP) channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ Res 1999;85:1146-53.
49. Vandenhoek TL, Becker LB, Shao ZH, Li CQ, Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 2000;86:541-8.
50. Motterlini R, Foresti R, Intaglietta M, Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 1996;270:H107-H114.
51. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications [review]. FASEB J 1988;2(10):2557-68.
52. Zhao L, Weber PA, Smith JR, Comerford ML, Elliott GT. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A. J Mol Cell Cardiol 1997;29(6):1567-76.
53. Xuan YT, Tang XL, Qiu Y, Banerjee S, Takano H, Han H, et al. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 2000;279(5):H2360-71.
54. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates post-ischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 2000;278(2):H643-51.
55. Clark JE, Foresti R, Green CJ, Motterlini R. Dynamics of hæm oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 2000;348:615-9.
56. Foresti R, Motterlini R. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res 1999;31:459-75.
57. Foresti R, Sarathchandra P, Clark JE, Green CJ, Motterlini R. Peroxynitrite induces hæm oxygenase-1 in vascular endothelial cells: a link to apoptosis. Biochem J 1999;339:729-36.
58. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999;103:129-35.